Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia

International Journal of Hematology

Volumn 93, Issue 4, 2011, Pages 494-501

  Liu, Hui ^a   Long, Juan ^a   Zhang, Peng Hui ^a   Li, Kang ^a   Tan, Jun Jie ^a   Sun, Bin ^a   Yu, Jie ^a   Tu, Zhi Guang ^a   Zou, Lin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Arrestin1; Acute lymphoblastic leukemia; Leukemia; Notch1

Indexed keywords

BETA ARRESTIN 1; NOTCH1 RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD CELL; CHILD; CONTROLLED STUDY; FEMALE; GENE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTOR VARIABLE; PRESCHOOL CHILD; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ARRESTINS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTOR, NOTCH1;

EID: 79955936152     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-011-0824-9     Document Type: Article

References (36)

1. Rana ZA, Rabbani MW, Sheikh MA, Khan AA. Outcome of childhood acute lymphoblastic leukaemia after induction therapy-3 years experience at a single paediatric oncology centre. J Ayub Med Coll Abbottabad. 2009;21:150-3.
2. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030-43. (Pubitemid 351389536)
3. Heuser M, Ganser A, Hoelzer D. The hematopoietic growth factors in acute leukemia: a European perspective. Cancer Treat Res. 2011;157:339-62.
4. Bauters T, Mondelaers V, Robays H, De Wilde H, Benoit Y, De Moerloose B. Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia. Pharm World Sci. 2010 [Epub ahead of print].
5. Karas Kuzelicki N, Milek M, Jazbec J, Mlinaric-Rascana I. 5,10-Methylenetetrahydrofolate reductase low activity genotypes reduce the risk of relapse-related acute lymphoblastic leukemia. Leuk Res. 2009;33:1344-8.
6. Rubnitz JE, Pui CH. Childhood acute lymphoblastic leukemia. Oncologist. 1997;2:374-80.
7. Butturini A, Arlinghaus RB Gale RP. BCR/ABL and leukemia. Leuk Res. 1996;20(5):23-9.
8. Mansur MB, Enmerenciano M, Splendore A, Brewer L, Hassan Rand Pombo-de-Oliveira MS. T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements. Leuk Res. 2010;34:483-6.
9. Lefkowitz RJ, Whalen EJ. Beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol. 2004;16:162-8. (Pubitemid 38757292)
10. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science. 2005;308:512-7.
11. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu Rev Physiol. 2007;69:483-510.
12. Luttrell LM, Lefkowitz RJ. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci. 2002;115:455-65. (Pubitemid 34182973)
13. Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ. Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell. 2009;17:443-58.
14. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, et al. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science. 2003;301:1394-7. (Pubitemid 37075818)
15. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Vaslcanu D, Girnita A, et al. Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J Biol Chem. 2007;282:11329-38. (Pubitemid 47100796)
16. Wang P, Gao H, Ni Y, Wang B, Wu Y, Ji L, et al. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J Biol Chem. 2003;278:6363-70. (Pubitemid 36800895)
17. Zou L, Yang R, Chai J, Pei G. Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis. FASEB J. 2008;22:355-64. (Pubitemid 351227345)
18. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci USA. 2006;103:1492-7. (Pubitemid 43191193)
19. Yue R, Kang J, Zhao C, Hu W, Tang Y, Liu X, et al. Beta-arrestin1 regulates zebrafish hematopoiesis through binding to YY1 and relieving polycomb group repression. Cell. 2009;139: 535-46.
20. Kalderon D. Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol. 2002;12:523-31. (Pubitemid 35346703)
21. Wilson JJ, Kovall RA. Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. Cell. 2006;124: 985-96. (Pubitemid 43344238)
22. Nam Y, Sliz P, Song L, Aster JC, Blacklow SC. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell. 2006;124:973-83. (Pubitemid 43344237)
23. Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2006;6:347-59.
24. Radtke F, Schweisguth F, Pear W. The Notch 'gospel'. EMBO Rep. 2005;6:1120-5.
25. Weng AP, Ferrando AA, Lee W, 4th Morris JP, Silverman LB, Sanchez-lrizarrv C, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306: 269-71. (Pubitemid 39336870)
26. Girard L, Hanna Z, Beaulieu N, Hoemann CD, Simard C, Kozak CA, et al. Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. Genes Dev. 1996;10:1930-44. (Pubitemid 26281687)
27. Feldman BJ, Hampton T, Cleary ML. A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2APBX1 transgenic mice. Blood. 2000;96:1906-13. (Pubitemid 30661076)
28. Beverly LJ, Capobianco AJ. Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis. Cancer Cell. 2003;3:551-64. (Pubitemid 36808650)
29. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-5.
30. Wolowiec D, Mekki Y, French P, Manel AM, Bertrand Y, Rimokh R, et al. Differential expression of cell proliferation regulatory proteins in B- and T-lineage acute lymphoblastic leukaemias. Br J Haematol. 1996;l95:518-23. (Pubitemid 26388694)
31. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996;14:18-24. (Pubitemid 26019992)
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-8. (Pubitemid 34164012)
33. Beaulieu JM, Caron MG. Beta-arrestin goes nuclear. Cell. 2005;123:755-7.
34. Matsubayashi J, Takanashi M, Oikawa K, Fujita K, Tanaka M, Xu M, et al. Expression of G protein-coupled receptor kinase 4 is associated with breast cancer tumourigenesis. J Pathol. 2008;216: 317-27.
35. Nobles KN, Guan Z, Xiao K, Oas TG, Lefkowitz RJ. The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2. J Biol Chem. 2007;282: 21370-81. (Pubitemid 47099966)
36. Kang J, Shi Y, Xaing B, Qu B, Su W, Zhu M, et al. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell. 2005;123:833-47. (Pubitemid 41721030)